select a format
NEWSLETTER BY CATEGORY
Recent Viewed Reports
Why Ken Reasearch?
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
KENCB10 - Avail a discount of 10% and cash back of 10% on all publications. Applicable on all licenses. Not Applicable on Ken Research Publications Limited Time Period Offer T&C apply
• Promo code can be used 1 time per user
Lead Pharma Holding B.V.-Product Pipeline Review-2015
Global Markets Direct's, 'Lead Pharma Holding B.V.-Product Pipeline Review-2015', provides an overview of the Lead Pharma Holding B.V.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Lead Pharma Holding B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report provides brief overview of Lead Pharma Holding B.V. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Lead Pharma Holding B.V.'s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Lead Pharma Holding B.V.'s pipeline products
Reasons To Buy
Evaluate Lead Pharma Holding B.V.'s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Lead Pharma Holding B.V. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Lead Pharma Holding B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Lead Pharma Holding B.V. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lead Pharma Holding B.V.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Lead Pharma Holding B.V. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Lead Pharma Holding B.V. Snapshot 4
Lead Pharma Holding B.V. Overview 4
Key Information 4
Key Facts 4
Lead Pharma Holding B.V.-Research and Development Overview 5
Key Therapeutic Areas 5
Lead Pharma Holding B.V.-Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products-Monotherapy 8
Lead Pharma Holding B.V.-Pipeline Products Glance 9
Lead Pharma Holding B.V.-Early Stage Pipeline Products 9
Discovery Products/Combination Treatment Modalities 9
Lead Pharma Holding B.V.-Drug Profiles 10
Small Molecule for Cancer 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
Small Molecule for Heart Failure-1 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Small Molecule for Heart Failure-2 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Small Molecules to Inhibit ROR gamma-t for Autoimmune Diseases 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Lead Pharma Holding B.V.-Pipeline Analysis 14
Lead Pharma Holding B.V.-Pipeline Products by Target 14
Lead Pharma Holding B.V.-Pipeline Products by Molecule Type 15
Lead Pharma Holding B.V.-Pipeline Products by Mechanism of Action 16
Lead Pharma Holding B.V.-Recent Pipeline Updates 17
Lead Pharma Holding B.V.-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 19
List of Tables
Lead Pharma Holding B.V., Key Information 4
Lead Pharma Holding B.V., Key Facts 4
Lead Pharma Holding B.V.-Pipeline by Indication, 2015 6
Lead Pharma Holding B.V.-Pipeline by Stage of Development, 2015 7
Lead Pharma Holding B.V.-Monotherapy Products in Pipeline, 2015 8
Lead Pharma Holding B.V.-Discovery, 2015 9
Lead Pharma Holding B.V.-Pipeline by Target, 2015 14
Lead Pharma Holding B.V.-Pipeline by Molecule Type, 2015 15
Lead Pharma Holding B.V.-Pipeline Products by Mechanism of Action, 2015 16
Lead Pharma Holding B.V.-Recent Pipeline Updates, 2015 17
Lead Pharma Holding B.V., Other Locations 18
Lead Pharma Holding B.V., Subsidiaries 18
List of Figures
Lead Pharma Holding B.V.-Pipeline by Top 10 Indication, 2015 6
Single User License:
Corporate User License:
Current R&D Portfolio of Lead Pharma Holding B.V.; Lead Pharma Holding B.V. - Key Therapeutics; Lead Pharma Holding B.V. - Pipeline Overview and Promising Molecules; Lead Pharma Holding B.V. - News; Lead Pharma Holding B.V. - Latest Updates; Lead Pharma Holding B.V. - Pipeline; Lead Pharma Holding B.V. - Discontinued/Dormant Projects